OSIVAX
Federal contractor profile
Total Awards
2
Total Obligated
$20.2M
Agencies Served
1
Expiring Contracts
1
Top Agencies
| Agency | Awards | Total Obligated |
|---|---|---|
| Department of Health and Human Services | 2 | $20.2M |
Top NAICS Codes
| NAICS Code | Description | Awards |
|---|---|---|
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | 2 |
All Awards
COST SHARINGNO SET ASIDE USED.
OSIVAX - CLINICAL PROOF OF CONCEPT OF OVX836, A SINGLE-SHOT BROADLY PROTECTIVE INFLUENZA A VACCINE FOR IMMEDIATE PROTECTION AGAINST EMERGING PANDEMIC STRAINS
Department of Health and Human Services75A50125C00008$19.5M
FIRM FIXED PRICENO SET ASIDE USED.
OXIVAX - AOI #28: INFLUENZA VACCINE INNOVATION. ADVANCING METAGENOMIC NEXT-GENERATION SEQUENCING BASED AGNOSTIC DIAGNOSTICS FOR VIRAL PATHOGENS THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO PREPARE THE IND PACKAGE FOR OVX836+SQ ADJUVANT.
Department of Health and Human Services75A50125C00006$743,969.31
Related
Teaming Partners